Please ensure Javascript is enabled for purposes of website accessibility Global Life Sciences Fund - Janus Henderson Investors
For Financial Professionals in the US

Global Life Sciences Fund Holdings

Full Portfolio Holdings

(As of 05/31/2024)

% OF INVESTMENTS
Eli Lilly & Co 8.56
UnitedHealth Group Inc 6.06
Novo Nordisk A/S 5.83
AstraZeneca PLC 3.81
AbbVie Inc 3.47
Merck & Co Inc 3.45
Amgen Inc 2.74
Sanofi SA 2.50
Boston Scientific Corp 2.46
Vertex Pharmaceuticals Inc 2.42
Novartis AG (ADR) 2.23
Abbott Laboratories 2.22
Thermo Fisher Scientific Inc 1.99
Danaher Corp 1.86
Sarepta Therapeutics Inc 1.83
Stryker Corp 1.75
Elevance Health Inc 1.65
Argenx SE (ADR) 1.58
Cencora Inc 1.52
Intuitive Surgical Inc 1.41
HCA Healthcare Inc 1.32
Madrigal Pharmaceuticals Inc 1.31
Vaxcyte Inc 1.31
Ascendis Pharma A/S (ADR) 1.28
Edwards Lifesciences Corp 1.26
Humana Inc 1.24
Globus Medical Inc 1.12
Roche Holding AG 1.11
United Therapeutics Corp 0.90
Avadel Pharmaceuticals PLC 0.87
Lantheus Holdings Inc 0.83
PTC Therapeutics Inc 0.81
Zoetis Inc 0.79
Neurocrine Biosciences Inc 0.77
Biohaven Ltd 0.77
Akero Therapeutics Inc 0.76
Dyne Therapeutics Inc 0.70
Centene Corp 0.69
Cooper Cos Inc 0.69
Teleflex Inc 0.66
Hoya Corp 0.66
Regeneron Pharmaceuticals Inc 0.66
STERIS PLC 0.65
Medtronic PLC 0.65
Johnson & Johnson 0.63
Ardelyx Inc 0.62
REVOLUTION Medicines Inc 0.60
Zai Lab Ltd (ADR) 0.54
DexCom Inc 0.51
ICON PLC 0.50
Ideaya Biosciences Inc 0.49
Insmed Inc 0.49
Arcellx Inc 0.48
Illumina Inc 0.47
4D Molecular Therapeutics Inc 0.47
Janux Therapeutics Inc 0.45
89bio Inc 0.45
Soleno Therapeutics Inc 0.45
Astellas Pharma Inc 0.42
Amicus Therapeutics Inc 0.42
Legend Biotech Corp (ADR) 0.40
Royalty Pharma plc 0.40
Mirum Pharmaceuticals Inc 0.39
Penumbra Inc 0.39
Cytokinetics Inc 0.37
Align Technology Inc 0.34
Gilead Sciences Inc 0.32
Sotera Health Co 0.32
Takeda Pharmaceutical Co Ltd 0.31
BioMarin Pharmaceutical Inc 0.30
DENTSPLY SIRONA Inc 0.29
Insmed Inc, 0.75%, 06/01/28 0.29
Bridgebio Pharma Inc 0.28
NeoGenomics Inc 0.28
Tandem Diabetes Care Inc 0.28
Crinetics Pharmaceuticals Inc 0.25
IQVIA Holdings Inc 0.24
Structure Therapeutics Inc (ADR) 0.24
Lexeo Therapeutics Inc 0.24
Rocket Pharmaceuticals Inc 0.22
Alnylam Pharmaceuticals Inc 0.22
Cargo Therapeutics Inc 0.20
Prothena Corp PLC 0.19
Rhythm Pharmaceuticals Inc 0.19
Catalyst Pharmaceuticals Inc 0.19
Intra-Cellular Therapies Inc 0.19
Bridgebio Pharma Inc 0.19
CG oncology Inc 0.19
New Horizon Health Ltd 0.18
Xenon Pharmaceuticals Inc 0.18
Catalent Inc 0.18
Collegium Pharmaceutical Inc 0.17
Merus NV 0.16
Immunome Inc 0.14
Perspective Therapeutics Inc 0.14
Crinetics Pharmaceuticals Inc 0.13
Heartflow Inc 0.12
Curevo Inc 0.11
Synthekine Inc 0.11
Shoreline Biosciences Inc 0.11
Bicara Therapeutics Inc 0.11
Element Biosciences Inc 0.10
Attralus Inc 0.10
Inspire Medical Systems Inc 0.09
Neurogene Inc 0.09
Neurogene Inc 0.08
Sonoma Biotherapeutics Inc 0.08
Biomea Fusion Inc 0.08
Neurogene Inc 0.07
Magnolia Medical Technologies Inc 0.06
Asher Biotherapeutics Inc 0.06
Sonoma Biotherapeutics Inc 0.04
Freenome Holdings Inc 0.04
Freenome Holdings Inc 0.04
Asher Biotherapeutics Inc 0.03
Twinstrand Biosciences Inc 0.03
Arbor Biotechnologies Inc 0.03
Magnolia Medical Technologies Inc, 10.00%, 12/31/25 0.00
Clementia Pharmaceuticals Inc 0.00
Hemoshear Therapeutics LLC 0.00
Cash & Equivalents 0.29
Janus Henderson publishes this listing of securities held as of the most recently available disclosure period, which varies depending on the portfolio. Any portion of holdings may be excluded from publication when deemed in the best interest of the portfolio. Securities are reported at market value.
The portfolio data and its presentation here is based on the investment book of record and may differ from the accounting book of record and complete schedules of investments in regulatory filings due to differing accounting and reporting standards.